26th Oct 2006 07:01
Evolutec Group PLC26 October 2006 Evolutec Group plc ("Evolutec" or the "Company") Dealings by Directors and Persons Discharging Managerial Responsibility The Company was informed that on 25 October 2006, David Bloxham (Non-ExecutiveChairman), Mark Carnegie Brown (Chief Executive Officer) and Nicholas Badman(Chief Financial Officer) acquired ordinary shares of 10p each in the Company ("Ordinary Shares"). Mr Bloxham acquired 5,000 Ordinary Shares in the Company, representingapproximately 0.02 per cent. of the Company's issued share capital, at a priceof 129p per Ordinary Share. Following this acquisition, Mr Bloxham holds 133,608Ordinary Shares, representing 0.51 per cent. of the Company's issued sharecapital following the placing announced on 25 October 2006 (the "Issued ShareCapital"). Mr Carnegie Brown acquired 7,000 Ordinary Shares, representing approximately0.03 per cent. of the Company's issued share capital, at a price of 129p perOrdinary Share. Following this acquisition, Mr Carnegie Brown holds 76,949Ordinary Shares, representing 0.30 per cent. of the Issued Share Capital. Mr Badman acquired 7,692 Ordinary Shares, representing approximately 0.03 percent. of the Company's issued share capital, at a price of 129p per OrdinaryShare. Following this acquisition, Mr Badman holds 76,621 Ordinary Shares,representing 0.30 per cent. of the Issued Share Capital. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Nanoco